A G-->A transition creates a branch point sequence and activation of a cryptic exon, resulting in the hereditary disorder neurofibromatosis 2.
暂无分享,去创建一个
P. Riegman | E. Zwarthoff | C. Avezaat | M. D. den Bakker | A. de Klein | M. Muijtjens | E. Bijlsma | A. Heldoorn
[1] J. Sambrook,et al. Molecular Cloning: A Laboratory Manual , 2001 .
[2] R. Hennekam,et al. Parental somatic and germ-line mosaicism for a FBN2 mutation and analysis of FBN2 transcript levels in dermal fibroblasts. , 1997, American journal of human genetics.
[3] M. Fornerod,et al. Interaction of cellular proteins with the leukemia specific fusion proteins DEK-CAN and SET-CAN and their normal counterpart, the nucleoporin CAN. , 1996, Oncogene.
[4] M. Kaiser-Kupfer,et al. Germ-line mutations in the neurofibromatosis 2 gene: correlations with disease severity and retinal abnormalities. , 1996, American journal of human genetics.
[5] R. Weksberg,et al. Type of mutation in the neurofibromatosis type 2 gene (NF2) frequently determines severity of disease. , 1996, American journal of human genetics.
[6] S. Jhanwar,et al. High frequency of inactivating mutations in the neurofibromatosis type 2 gene (NF2) in primary malignant mesotheliomas. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[7] T. H. van der Kwast,et al. Neurofibromatosis type 2 protein co-localizes with elements of the cytoskeleton. , 1995, The American journal of pathology.
[8] J. Minna,et al. Neurofibromatosis type 2 (NF2) gene is somatically mutated in mesothelioma but not in lung cancer. , 1995, Cancer research.
[9] P. Riegman,et al. Cytogenetic, Molecular Genetic and Pathological Analyses in 126 Meningiomas , 1995, Journal of neuropathology and experimental neurology.
[10] A. Hagemeijer,et al. Frequent NF2 gene transcript mutations in sporadic meningiomas and vestibular schwannomas. , 1994, American journal of human genetics.
[11] J. Gusella,et al. Exon scanning for mutation of the NF2 gene in schwannomas. , 1994, Human molecular genetics.
[12] J. Gusella,et al. Mutations in transcript isoforms of the neurofibromatosis 2 gene in multiple human tumour types , 1994, Nature Genetics.
[13] S. Pulst,et al. Alteration in a new gene encoding a putative membrane-organizing protein causes neuro-fibromatosis type 2 , 1993, Nature.
[14] J. Haines,et al. A novel moesin-, ezrin-, radixin-like gene is a candidate for the neurofibromatosis 2 tumor suppressor , 1993, Cell.
[15] André Rosenthal,et al. Aberrant splicing of neural cell adhesion molecule L1 mRNA in a family with X–linked hydrocephalus , 1992, Nature Genetics.
[16] D. Evans,et al. A clinical study of type 2 neurofibromatosis. , 1992, The Quarterly journal of medicine.
[17] T. Maniatis,et al. The role of the mammalian branchpoint sequence in pre-mRNA splicing. , 1988, Genes & development.
[18] G. Bleeker,et al. Meningiomas in five members of a family over two generations, in one member simultaneously with acoustic neurinomas , 1978, Neurology.
[19] E. Zwarthoff. Neurofibromatosis and associated tumour suppressor genes. , 1996, Pathology, research and practice.